Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAPK7 Antikörper (C-Term, Isoform 1)

MAPK7 Reaktivität: Human, Maus, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN966526
  • Target Alle MAPK7 Antikörper anzeigen
    MAPK7 (Mitogen-Activated Protein Kinase 7 (MAPK7))
    Bindungsspezifität
    • 16
    • 16
    • 15
    • 15
    • 15
    • 15
    • 10
    • 9
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term, Isoform 1
    Reaktivität
    • 92
    • 62
    • 57
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Human, Maus, Ratte
    Wirt
    • 120
    • 4
    • 2
    • 1
    Kaninchen
    Klonalität
    • 115
    • 12
    Polyklonal
    Konjugat
    • 38
    • 10
    • 8
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 1
    Dieser MAPK7 Antikörper ist unkonjugiert
    Applikation
    • 68
    • 54
    • 53
    • 36
    • 23
    • 18
    • 17
    • 13
    • 7
    • 5
    • 3
    • 1
    • 1
    Immunohistochemistry (IHC)
    Immunogen
    Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to C-terminal residues of human MAPK7 (mitogen-activated protein kinase 7 isoform 1)
    Top Product
    Discover our top product MAPK7 Primärantikörper
  • Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Lagerung
    4 °C
  • Sawhney, Liu, Brattain: "A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling." in: Journal of cellular physiology, Vol. 219, Issue 1, pp. 152-61, (2009) (PubMed).

    Zhao, Geng, Ge, Wang, Zhang, Kang: "Activation of ERK5 in angiotensin II-induced hypertrophy of human aortic smooth muscle cells." in: Molecular and cellular biochemistry, Vol. 322, Issue 1-2, pp. 171-8, (2009) (PubMed).

    Montero, Ocaña, Abad, Ortiz-Ruiz, Pandiella, Esparís-Ogando: "Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target." in: PLoS ONE, Vol. 4, Issue 5, pp. e5565, (2009) (PubMed).

    Zen, Yasui, Nakajima, Zen, Zen, Gen, Mitsuyoshi, Minami, Mitsufuji, Tanaka, Itoh, Nakanuma, Taniwaki, Arii, Okanoue, Yoshikawa: "ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry." in: Genes, chromosomes & cancer, Vol. 48, Issue 2, pp. 109-20, (2008) (PubMed).

    Arnoux, Nassour, LHelgoualch, Hipskind, Savagner: "Erk5 controls Slug expression and keratinocyte activation during wound healing." in: Molecular biology of the cell, Vol. 19, Issue 11, pp. 4738-49, (2008) (PubMed).

    Buschbeck, Eickhoff, Sommer, Ullrich: "Phosphotyrosine-specific phosphatase PTP-SL regulates the ERK5 signaling pathway." in: The Journal of biological chemistry, Vol. 277, Issue 33, pp. 29503-9, (2002) (PubMed).

    Esparís-Ogando, Díaz-Rodríguez, Montero, Yuste, Crespo, Pandiella: "Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2." in: Molecular and cellular biology, Vol. 22, Issue 1, pp. 270-85, (2001) (PubMed).

    Purandare, Lee, Patel: "Assignment of big MAP kinase (PRKM7) to human chromosome 17 band p11.2 with somatic cell hybrids." in: Cytogenetics and cell genetics, Vol. 83, Issue 3-4, pp. 258-9, (1999) (PubMed).

    Kato, Tapping, Huang, Watson, Ulevitch, Lee: "Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor." in: Nature, Vol. 395, Issue 6703, pp. 713-6, (1998) (PubMed).

    English, Pearson, Baer, Cobb: "Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinases." in: The Journal of biological chemistry, Vol. 273, Issue 7, pp. 3854-60, (1998) (PubMed).

  • Target
    MAPK7 (Mitogen-Activated Protein Kinase 7 (MAPK7))
    Andere Bezeichnung
    MAPK7 (MAPK7 Produkte)
    Synonyme
    BMK1 antikoerper, ERK4 antikoerper, ERK5 antikoerper, PRKM7 antikoerper, Erk5-T antikoerper, ATMPK7 antikoerper, F8D23.5 antikoerper, F8D23_5 antikoerper, MAP kinase 7 antikoerper, Bmk1 antikoerper, Erk5 antikoerper, Prkm7 antikoerper, ERK-5 antikoerper, bmk1 antikoerper, erk4 antikoerper, mapk7 antikoerper, prkm7 antikoerper, mitogen-activated protein kinase 7 antikoerper, MAP kinase 7 antikoerper, mitogen-activated protein kinase 7 L homeolog antikoerper, MAPK7 antikoerper, Mapk7 antikoerper, MPK7 antikoerper, mapk7.L antikoerper
    Hintergrund
    MAPK7 (mitogen-activated protein kinase 7 isoform 1) is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is specifically activated by mitogen-activated protein kinase kinase 5 (MAP2K5/MEK5). It is involved in the downstream signaling processes of various receptor molecules including receptor type kinases, and G protein-coupled receptors. In response to extracelluar signals, this kinase translocates to cell nucleus, where it regulates gene expression by phosphorylating, and activating different transcription factors. Four alternatively spliced transcript variants of this gene encoding two distinct isoforms have been reported.
    Synonyms: BMK1, ERK4, ERK5, PRKM7
    Pathways
    MAPK Signalweg, Neurotrophin Signalübertragung, Activation of Innate immune Response, cAMP Metabolic Process, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling
Sie sind hier:
Kundenservice